EZH2 inhibition via GSK-126 mitigates EndMT and atherosclerosis in diabetes: A translational epigenetic approach

Journal:

Science Advances

Published:

2026-05-29

DOI:

10.1126/sciadv.aee5560

Affiliations:

4

Authors:

11

Go to article

Institutions	Authors	Share
Monash University, Australia	8.000000	0.73
Baker Heart and Diabetes Institute (Baker IDI), Australia	2.000000	0.18
UW Medicine, United States of America (USA)	0.500000	0.05
German Diabetes Center - Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf (DDZ), Germany	0.500000	0.05

Interested in Cardiovascular Medicine and Haematology?